Company Name, Ticker, Customers, else..

Haemonetics Corporation (NYSE: HAE)

Sector • Healthcare Industry • Medical Equipment & Supplies

Industry • Medical Equipment & Supplies

Sector • Healthcare

Haemonetics's

Name: Haemonetics Corporation Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HAE Sales vs. its Competitors Q4 2026

Comparing the current results to its competitors, Haemonetics reported Revenue increase in the 4 quarter 2026 by 4.88 % year on year.
The sales growth was above Haemonetics's competitors' average revenue growth of 0.59 %, achieved in the same quarter.

• List of HAE Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Haemonetics Corporation, slower than the average decrease reported by the company's competitors of -48.51 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -48.51 %

<< HAE Stock Performance Comparisons

Haemonetics's Comment on Competition and Industry Peers

The company utilizes patents, unpatented know-how, trade secrets, and the technical expertise of its personnel to sustain its competitive position. It is involved in intellectual property litigation to enforce its patent rights and safeguard its trade secrets. However, patents issued or licensed to the company may be subject to challenges or invalidation by competitors.

<< See the full list of HAE competitors

Overall company Market Share Q4 2026

Overall company revenue, increased by 4.88 % faster than Haemonetics's competitors within this division and its market share improved to approx. 1.62 %. << More on HAE Market Share.

*Market share is calculated based on total revenue.

HAE's Stock Performance relative to its Competitors

Publicly Traded Peers of Haemonetics Corporation

Cerus Corporation
Share Performance

-2.26%

Over The Past 5 Days

Cerus Corporation

Profile

Cerus Corporation's business model revolves around developing and commercializing innovative technologies and products for the enhancement of blood safety.

More about Cerus Corporation's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 502.828 mill.	$ 215.758 mill.	$ -9.567 mill.

Precision Optics Corporation Inc
Share Performance

-1.14%

Over The Past 5 Days

Precision Optics Corporation Inc

Profile

Precision Optics Corporation Inc is a company that specializes in designing and manufacturing advanced optical systems for medical and defense industries. They focus on delivering high-precision solutions to meet the complex optical needs of their customers.

More about Precision Optics Corporation Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 33.905 mill.	$ 28.939 mill.	$ -4.929 mill.

Livanova Plc
Share Performance

+8.10%

30 Days

Livanova Plc

Profile

Livanova Plc is a global medical technology company that focuses on developing and delivering innovative solutions for patients with cardiovascular diseases and neuropsychiatric disorders. Through their diverse portfolio, they offer products and therapies that encompass surgical heart valves, cardiac rhythm management, and neuromodulation. Livanova adopts a patient-centric approach, collaborating with healthcare professionals to improve patient outcomes and enhance quality of life.

More about Livanova Plc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 4,582.932 mill.	$ 1,432.049 mill.	$ 107.145 mill.

Koru Medical Systems Inc
Share Performance

-42.07%

This Year

Koru Medical Systems Inc

Profile

Koru Medical Systems Inc has a business model centered around providing medical solutions or services.

More about Koru Medical Systems Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 150.686 mill.	$ 43.257 mill.	$ -2.279 mill.

Icu Medical Inc
Share Performance

+28.39%

This Quarter

Icu Medical Inc

Profile

ICU Medical Inc's business model focuses on the development, manufacture, and sale of innovative medical devices and solutions for critical care settings.

More about Icu Medical Inc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 4,220.000 mill.	$ 2,156.379 mill.	$ 46.340 mill.

7 more competitors available

Sources: Haemonetics Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 5, 2026 7:46 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Haemonetics Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.